{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:42:38Z","timestamp":1792172558026,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cellimm.2023.104776","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T09:51:13Z","timestamp":1697363473000},"page":"104776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Ro52\/TRIM21 \u2013 From host defense to autoimmunity"],"prefix":"10.1016","volume":"393-394","author":[{"given":"Emilia","family":"Holwek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Opinc-Rosiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-8551","authenticated-orcid":false,"given":"Joanna","family":"Sarnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-375X","authenticated-orcid":false,"given":"Joanna","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2023.104776_b0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwv292","article-title":"Prediction and Prevention of Autoimmune Disease in the 21st Century: A Review and Preview","volume":"183","author":"Rose","year":"2016","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.cellimm.2023.104776_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human Autoimmune Diseases: A Comprehensive Update","volume":"278","author":"Wang","year":"2015","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The Immunobiology of Ro52 (TRIM21) in Autoimmunity: A Critical Review","volume":"39","author":"Oke","year":"2012","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.cellimm.2023.104776_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738473","article-title":"TRIM21\/Ro52 - Roles in Innate Immunity and Autoimmune Disease","volume":"12","author":"Jones","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103013","article-title":"An Updated Review of Anti-Ro52 (TRIM21) Antibodies Impact in Connective Tissue Diseases Clinical Management","volume":"21","author":"Decker","year":"2022","journal-title":"Autoimmunity Reviews"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cei.13402","article-title":"Longitudinal Anti-Nuclear Antibody (ANA) Seroconversion in Systemic Lupus Erythematosus: A Prospective Study of Swedish Cases with Recent-Onset Disease","volume":"199","author":"Frodlund","year":"2020","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0035","first-page":"1","article-title":"Clinical Significance of Different Profiles of Anti-Ro Antibodies in Connective Tissue Diseases","volume":"2023","author":"Yang","year":"2023","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.cellimm.2023.104776_b0040","doi-asserted-by":"crossref","first-page":"1044812","DOI":"10.3389\/fped.2022.1044812","article-title":"Clinical and Laboratory Features of Childhood-Onset Primary Sj\u00f6gren\u2019s Syndrome: A Retrospective Study from China","volume":"10","author":"Liu","year":"2022","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.cellimm.2023.104776_b0045","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/ijms24021683","article-title":"Multiple Roles of TRIM21 in Virus Infection","volume":"24","author":"Li","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.cellimm.2023.104776_b0050","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","article-title":"A 52-kD Protein Is a Novel Component of the SS-A\/Ro Antigenic Particle","volume":"167","author":"Ben-Chetrit","year":"1988","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gene.2011.21","article-title":"IRF7: Activation, Regulation, Modification and Function","volume":"12","author":"Ning","year":"2011","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.cellimm.2023.104776_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12016-021-08911-z","article-title":"Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome When Associated with Interstitial Lung Disease in Systemic Sclerosis and Autoimmune Myositis","volume":"63","author":"Chan","year":"2022","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0065","unstructured":"Transcript: TRIM21-201 (ENST00000254436.8) - Protein Summary - Homo_sapiens - Ensembl Genome Browser 103 Available online: http:\/\/feb2021.archive.ensembl.org\/Homo_sapiens\/Transcript\/ProteinSummary?g=ENSG00000132109;r=11:4384897-4393702;t=ENST00000254436 (accessed on 25 May 2023)."},{"key":"10.1016\/j.cellimm.2023.104776_b0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molimm.2005.04.013","article-title":"Structural, Functional and Immunologic Characterization of Folded Subdomains in the Ro52 Protein Targeted in Sj\u00f6gren\u2019s Syndrome","volume":"43","author":"Ottosson","year":"2006","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0075","article-title":"Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21","volume":"7","author":"Dickson","year":"2018","journal-title":"Intracellular Antibody Signalling Is Regulated by Phosphorylation of the Fc Receptor TRIM21."},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41594-021-00560-2","article-title":"Target-Induced Clustering Activates Trim-Away of Pathogens and Proteins","volume":"28","author":"Zeng","year":"2021","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.cellimm.2023.104776_b0085","doi-asserted-by":"crossref","unstructured":"A. Wallenhammar M. Anandapadamanaban A. Lemak C. Mirabello P. Lundstr\u00f6m B. Wallner M. Sunnerhagen O. Mayans Solution NMR Structure of the TRIM21 B-Box2 and Identification of Residues Involved in Its Interaction with the RING Domain PLOS ONE 12 7 2017 10.1371\/journal.pone.0181551 e0181551 e0181551.","DOI":"10.1371\/journal.pone.0181551"},{"key":"10.1016\/j.cellimm.2023.104776_b0090","doi-asserted-by":"crossref","unstructured":"McEwan, W.A.; James, L.C. Chapter Six - TRIM21-Dependent Intracellular Antibody Neutralization of Virus Infection. In Progress in Molecular Biology and Translational Science; Klasse, P.J., Ed.; The Molecular Basis of Viral Infection; Academic Press, 2015; Vol. 129, pp. 167\u2013187.","DOI":"10.1016\/bs.pmbts.2014.10.006"},{"key":"10.1016\/j.cellimm.2023.104776_b0095","doi-asserted-by":"crossref","unstructured":"S. Foss M. Bottermann A. Jonsson I. Sandlie L.C. James J.T. Andersen TRIM21\u2014From Intracellular Immunity to Therapy Front. Immunol. 10 2019 doi:10.3389\/fimmu.2019.02049.","DOI":"10.3389\/fimmu.2019.02049"},{"key":"10.1016\/j.cellimm.2023.104776_b0100","unstructured":"TRIM21 Protein Expression Summary - The Human Protein Atlas Available online: https:\/\/www.proteinatlas.org\/ENSG00000132109-TRIM21 (accessed on 22 May 2023)."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104776_b0105","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1084\/jem.182.4.983","article-title":"52-kD SS-A\/Ro: Genomic Structure and Identification of an Alternatively Spliced Transcript Encoding a Novel Leucine Zipper-Minus Autoantigen Expressed in Fetal and Adult Heart","volume":"182","author":"Chan","year":"1995","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/1529-0131(200103)44:3<638::AID-ANR112>3.0.CO;2-J","article-title":"Polymorphisms of the Ro52 Gene Associate with Anti-Ro 52-Kd Autoantibodies in Patients with Primary Sj\u00f6gren\u2019s Syndrome","volume":"44","author":"Nakken","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104776_b0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2011.12.010","article-title":"SS-A\/Ro52 Promotes Apoptosis by Regulating Bcl-2 Production","volume":"417","author":"Jauharoh","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cellimm.2023.104776_b0120","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00296-017-3718-1","article-title":"A Review of the Role and Clinical Utility of Anti-Ro52\/TRIM21 in Systemic Autoimmunity","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatology International"},{"key":"10.1016\/j.cellimm.2023.104776_b0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.1993.tb03436.x","article-title":"Sera from Patients with Rheumatic Diseases Recognize Different Epitope Regions on the 52-kD Ro\/SS-A Protein","volume":"94","author":"Bozic","year":"1993","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 Antibodies Frequently Co-Occur with Anti-Jo-1 Antibodies in Sera from Patients with Idiopathic Inflammatory Myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clinical and Experimental Immunology"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0135","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-\u03b2 Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00098","article-title":"TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis","volume":"11","author":"Kunishita","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0145","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/febs.14654","article-title":"Advances and Challenges in Targeting IRF5, a Key Regulator of Inflammation","volume":"286","author":"Almuttaqi","year":"2019","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.cellimm.2023.104776_b0150","article-title":"The Emerging Roles of TRIM21 in Coordinating Cancer Metabolism","volume":"13","author":"Chen","year":"2022","journal-title":"Immunity and Cancer Treatment. Front. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2023.104776_b0155","doi-asserted-by":"crossref","first-page":"e11776","DOI":"10.1371\/journal.pone.0011776","article-title":"Self Protection from Anti-Viral Responses - Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-like Receptors","volume":"5","author":"Higgs","year":"2010","journal-title":"PLoS One1"},{"key":"10.1016\/j.cellimm.2023.104776_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cytogfr.2020.03.003","article-title":"Interferon Regulatory Factor 8 Governs Myeloid Cell Development","volume":"55","author":"Xia","year":"2020","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"9","key":"10.1016\/j.cellimm.2023.104776_b0165","first-page":"2456","article-title":"TRIM21 Is Targeted for Chaperone-Mediated Autophagy during Salmonella Typhimurium Infection","volume":"205","author":"Hos","year":"2020","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.cellimm.2023.104776_b0170","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.molcel.2016.02.007","article-title":"TRIM21 Ubiquitylates SQSTM1\/P62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis","volume":"61","author":"Pan","year":"2016","journal-title":"Molecular Cell"},{"key":"10.1016\/j.cellimm.2023.104776_b0175","unstructured":"Severe Fever with Thrombocytopenia Syndrome Virus NSs Interacts with TRIM21 To Activate the P62-Keap1-Nrf2 Pathway Available online: https:\/\/journals.asm.org\/doi\/epub\/10.1128\/jvi.01684-19 (accessed on 1 June 2023)."},{"key":"10.1016\/j.cellimm.2023.104776_b0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cei.12432","article-title":"Toll-like Receptor 3 Stimulation Promotes Ro52\/TRIM21 Synthesis and Nuclear Redistribution in Salivary Gland Epithelial Cells, Partially via Type I Interferon Pathway","volume":"178","author":"Kyriakidis","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cei.12341","article-title":"Ductal Epithelial Expression of Ro52 Correlates with Inflammation in Salivary Glands of Patients with Primary Sj\u00f6gren\u2019s Syndrome","volume":"177","author":"Aqrawi","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0190","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/jid.2008.453","article-title":"High Ro52 Expression in Spontaneous and UV-Induced Cutaneous Inflammation","volume":"129","author":"Oke","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104776_b0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41418-021-00867-z","article-title":"TRIM21 Regulates Pyroptotic Cell Death by Promoting Gasdermin D Oligomerization","volume":"29","author":"Gao","year":"2022","journal-title":"Cell Death and Differentiation"},{"issue":"10","key":"10.1016\/j.cellimm.2023.104776_b0200","first-page":"1987","article-title":"TRIM21 Regulates Virus-Induced Cell Pyroptosis through Polyubiquitination of ISG12a","volume":"209","author":"Guo","year":"2022","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.cellimm.2023.104776_b0205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/exd.13269","article-title":"TRIM21 Is Important in the Early Phase of Inflammation in the Imiquimod-Induced Psoriasis-like Skin Inflammation Mouse Model","volume":"26","author":"Vinter","year":"2017","journal-title":"Experimental Dermatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/718237","article-title":"Autoantigen TRIM21\/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus","volume":"2012","author":"Yoshimi","year":"2012","journal-title":"International Journal of Rheumatology"},{"issue":"12","key":"10.1016\/j.cellimm.2023.104776_b0215","first-page":"7527","article-title":"Gene Disruption Study Reveals a Non-Redundant Role for TRIM21\/Ro52 in NF-\u03baB-Dependent Cytokine Expression in Fibroblasts","volume":"182","author":"Chang","year":"2009","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.cellimm.2023.104776_b0220","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the Lupus Autoantigen Ro52\/Trim21 Induces Tissue Inflammation and Systemic Autoimmunity by Deregulating the IL-23\u2013Th17 Pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00444","article-title":"Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52\/TRIM21 Antibody Detection in Autoimmune Diseases","volume":"10","author":"Robbins","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104776_b0230","doi-asserted-by":"crossref","first-page":"e93812","DOI":"10.1371\/journal.pone.0093812","article-title":"Clinical and Serological Features of Patients Referred through a Rheumatology Triage System Because of Positive Antinuclear Antibodies","volume":"9","author":"Fitch-Rogalsky","year":"2014","journal-title":"PLoS One1"},{"key":"10.1016\/j.cellimm.2023.104776_b0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/03009740510017940","article-title":"The Serological Pattern of Autoantibodies to the Ro52, Ro60, and La48 Autoantigens in Primary Sj\u00f6gren\u2019s Syndrome Patients and Healthy Controls","volume":"34","author":"Garberg","year":"2005","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jclinpath-2015-203587","article-title":"Clinical Associations of the Positive Anti Ro52 without Ro60 Autoantibodies: Undifferentiated Connective Tissue Diseases","volume":"71","author":"Murng","year":"2018","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.cellimm.2023.104776_b0245","unstructured":"RO60 Protein Expression Summary - The Human Protein Atlas Available online: https:\/\/www.proteinatlas.org\/ENSG00000116747-RO60 (accessed on 15 September 2023)."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104776_b0250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical Significance of Anti-Ro52 (TRIM21) Antibodies Non-Associated with Anti-SSA 60kDa Antibodies: Results of a Multicentric Study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.cellimm.2023.104776_b0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical Associations of Anti-SSA\/Ro60 and Anti-Ro52\/TRIM21 Antibodies: Diagnostic Utility of Their Separate Detection","volume":"46","author":"Men\u00e9ndez","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cellimm.2023.104776_b0260","first-page":"S134","article-title":"Anti-Ro52 and\/or Anti-Ro60 Immune Reactivity: Autoantibody and Disease Associations","volume":"38","author":"Zampeli","year":"2021","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0265","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.61.12.1090","article-title":"Diagnostic Associations in a Large and Consecutively Identified Population Positive for Anti-SSA and\/or Anti-SSB: The Range of Associated Diseases Differs According to the Detailed Serotype","volume":"61","author":"Peene","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cellimm.2023.104776_b0270","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s10067-022-06299-5","article-title":"Anti-Ro52\/TRIM21 Serological Subsets Identify Differential Clinical and Laboratory Parameters","volume":"41","author":"Lee","year":"2022","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.reuma.2015.10.010","article-title":"Association of Anti-Ro52, Anti-Ro60 and Anti-La Antibodies with Diagnostic, Clinical and Laboratory Features in a Referral Hospital in Jerez","volume":"12","author":"Menor Almagro","year":"2016","journal-title":"Spain. Reumatol. Cl\u00ednica Engl. Ed."},{"issue":"1012","key":"10.1016\/j.cellimm.2023.104776_b0280","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/pgmj.2009.089656","article-title":"Diagnostic Utility of Anti-Ro52 Detection in Systemic Autoimmunity","volume":"86","author":"Dugar","year":"2010","journal-title":"Postgraduate Medical Journal"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0285","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","article-title":"Interaction between Innate Immunity and Ro52-Induced Antibody Causes Sj\u00f6gren\u2019s Syndrome-like Disorder in Mice","volume":"75","author":"Szczerba","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cellimm.2023.104776_b0290","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/ijms19102935","article-title":"Immune Response Targeting Sj\u00f6gren\u2019s Syndrome Antigen Ro52 Suppresses Tear Production in Female Mice","volume":"19","author":"Trzeciak","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"20","key":"10.1016\/j.cellimm.2023.104776_b0295","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015578","article-title":"Clinical Significance of Myositis-Specific Autoantibody Profiles in Japanese Patients with Polymyositis\/Dermatomyositis","volume":"98","author":"Temmoku","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cellimm.2023.104776_b0300","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0961203313479420","article-title":"Autoantibodies to the Functionally Active RING-Domain of Ro52\/SSA Are Associated with Disease Activity in Patients with Lupus","volume":"22","author":"Kvarnstr\u00f6m","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2023.104776_b0305","first-page":"686","article-title":"Anti-Ro52 Antibody Testing Influences the Classification and Clinical Characterisation of Primary Sj\u00f6gren\u2019s Syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0310","doi-asserted-by":"crossref","first-page":"987","DOI":"10.5604\/17322693.1117543","article-title":"Serological Profile of Patients with Systemic Sclerosis","volume":"68","author":"Wielosz","year":"2014","journal-title":"Post\u00c8\u00a9py Higieny i Medycyny Do\u00c5\u203awiadczalnej"},{"key":"10.1016\/j.cellimm.2023.104776_b0315","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic Accuracy and Predictive Value of Extended Autoantibody Profile in Systemic Sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.cellimm.2023.104776_b0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203306073135","article-title":"Fine Specificity of the Ro\/SSA Autoantibody Response in Relation to Serological and Clinical Findings in 96 Patients with Self-Reported Cutaneous Symptoms Induced by the Sun","volume":"16","author":"Popovic","year":"2007","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104776_b0325","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3164\/jcbn.20-5","article-title":"Auto-Antibody Evaluation in Idiopathic Interstitial Pneumonia and Worse Survival of Patients with Ro52\/TRIM21auto-Antibody","volume":"67","author":"Morita","year":"2020","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"key":"10.1016\/j.cellimm.2023.104776_b0330","article-title":"Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"11","author":"Yang","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0335","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13679","article-title":"Anti-Ro52 Antibodies in Clinical Practice: A Single-Centre Experience","volume":"75","author":"Wu","year":"2021","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.cellimm.2023.104776_b0340","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1231-7","article-title":"Presentations and Outcomes of Interstitial Lung Disease and the Anti-Ro52 Autoantibody","volume":"20","author":"Sclafani","year":"2019","journal-title":"Respiratory Research"},{"key":"10.1016\/j.cellimm.2023.104776_b0345","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-3083.2001.00993.x","article-title":"Associations of MHC Class II Alleles in Norwegian Primary Sj\u00f6gren\u2019s Syndrome Patients: Implications for Development of Autoantibodies to the Ro52 Autoantigen","volume":"54","author":"Nakken","year":"2001","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.cellimm.2023.104776_b0350","unstructured":"SSB Protein Expression Summary - The Human Protein Atlas Available online: https:\/\/www.proteinatlas.org\/ENSG00000138385-SSB (accessed on 15 September 2023)."},{"key":"10.1016\/j.cellimm.2023.104776_b0355","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/jcm9072299","article-title":"Current State of Knowledge on Primary Sj\u00f6gren\u2019s Syndrome, an Autoimmune Exocrinopathy","volume":"9","author":"Parisis","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0360","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/ijmr.IJMR_1356_15","article-title":"Clinical & Immunological Characteristics in Systemic Lupus Erythematosus Patients","volume":"146","author":"Rastin","year":"2017","journal-title":"The Indian Journal of Medical Research"},{"key":"10.1016\/j.cellimm.2023.104776_b0365","article-title":"The Clinical Significance of Antinuclear Antibodies and Specific Autoantibodies in Juvenile and Adult Systemic Lupus Erythematosus Patients","author":"Rodsaward","year":"2020","journal-title":"Asian Pacific Journal of Allergy and Immunology"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104776_b0370","doi-asserted-by":"crossref","first-page":"e32001","DOI":"10.1371\/journal.pone.0032001","article-title":"Two Major Autoantibody Clusters in Systemic Lupus Erythematosus","volume":"7","author":"Ching","year":"2012","journal-title":"PLoS One1"},{"key":"10.1016\/j.cellimm.2023.104776_b0375","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/14397595.2016.1208136","article-title":"Anti-Ro\/SSA Antibodies Are Associated with Severe Mitral Valve Regurgitation in Patients with Systemic Lupus Erythematosus","volume":"27","author":"Higuera-Ortiz","year":"2017","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0380","doi-asserted-by":"crossref","DOI":"10.1186\/ar1198","article-title":"Autoantibody Profile in Systemic Lupus Erythematosus with Psychiatric Manifestations: A Role for Anti-Endothelial-Cell Antibodies","volume":"6","author":"Conti","year":"2004","journal-title":"Arthritis Research & Therapy"},{"issue":"13","key":"10.1016\/j.cellimm.2023.104776_b0385","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1177\/09612033211042293","article-title":"Anti-TRIM21 Antibody Is Associated with Aberrant B-Cell Function and Type I Interferon Production in Systemic Lupus Erythematosus","volume":"30","author":"Kunishita","year":"2021","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.cellimm.2023.104776_b0390","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/14397595.2018.1436028","article-title":"Dysfunction of TRIM21 in Interferon Signature of Systemic Lupus Erythematosus","volume":"28","author":"Kamiyama","year":"2018","journal-title":"Modern Rheumatology"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104776_b0395","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of Autoantibodies in 100 Patients with Autoimmune Myositis: Insights into Clinical Features and Outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.cellimm.2023.104776_b0400","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody Profiles in the Sera of European Patients with Myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cellimm.2023.104776_b0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2017.10.002","article-title":"An Effective Algorithm for the Serological Diagnosis of Idiopathic Inflammatory Myopathies: The Key Role of Anti-Ro52 Antibodies","volume":"475","author":"Infantino","year":"2017","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.cellimm.2023.104776_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.954937","article-title":"Profile of Specific and Associated Autoantibodies in Patients with Idiopathic Inflammatory Myopathies in a Colombian Population","volume":"9","author":"Hormaza-Jaramillo","year":"2022","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0415","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.rmed.2019.07.020","article-title":"Clinical Characteristics of Dermatomyositis Patients with Isolated Anti-Ro-52 Antibody Associated Rapid Progressive Interstitial Lung Disease: Data from the Largest Single Chinese Center","volume":"155","author":"Chen","year":"2019","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0420","first-page":"147","article-title":"Mechanic\u2019s Hands in a Patient with Isolated Anti-Ro52 Antibodies: Antisynthetase Syndrome without Antisynthetase Antibodies","volume":"18","author":"Korsten","year":"2020","journal-title":"JDDG - J. Ger. Soc. Dermatol."},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0425","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/14397595.2015.1091155","article-title":"Clinical Subsets Associated with Different Anti-Aminoacyl Transfer RNA Synthetase Antibodies and Their Association with Coexisting Anti-Ro52","volume":"26","author":"Yamasaki","year":"2016","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0430","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 Autoantibodies Are Associated with Interstitial Lung Disease and More Severe Disease in Patients with Juvenile Myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cellimm.2023.104776_b0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10067-007-0762-3","article-title":"Anti-Ro52 Antibodies, Antisynthetase Antibodies, and Antisynthetase Syndrome","volume":"27","author":"Limaye","year":"2008","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0440","first-page":"722","article-title":"Immunoserological Aspects of Idiopathic Inflammatory Muscle Disease","volume":"112","author":"Rozman","year":"2000","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"13","key":"10.1016\/j.cellimm.2023.104776_b0445","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and Extramuscular Features of Myositis Patients with Anti-U1-RNP Autoantibodies","volume":"92","author":"Casal-Dominguez","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cellimm.2023.104776_b0450","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","article-title":"Myositis-Specific and Myositis-Associated Autoantibody Profiles and Their Clinical Associations in a Large Series of Patients with Polymyositis and Dermatomyositis","volume":"68","author":"Cruellas","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.cellimm.2023.104776_b0455","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/jaut.1998.0265","article-title":"The Association of Anti-Ro52 Autoantibodies with Myositis and Scleroderma Autoantibodies","volume":"12","author":"Frank","year":"1999","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.cellimm.2023.104776_b0460","doi-asserted-by":"crossref","first-page":"102491","DOI":"10.1016\/j.msard.2020.102491","article-title":"Complete Spinal Cord Involvement from Neuromyelitis Optica Spectrum Disorder in an Adult Female with Anti-Synthetase Syndrome","volume":"46","author":"Wang","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104776_b0465","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical Significance of Antibodies to Ro52\/TRIM21 in Systemic Sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Research & Therapy"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0470","doi-asserted-by":"crossref","first-page":"e0214202","DOI":"10.1371\/journal.pone.0214202","article-title":"Autoantibodies Are Present before the Clinical Diagnosis of Systemic Sclerosis","volume":"14","author":"Burbelo","year":"2019","journal-title":"PLoS One1"},{"key":"10.1016\/j.cellimm.2023.104776_b0475","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/s101650200035","article-title":"Subclinical Sj\u00f6gren\u2019s Syndrome and Anti-Ro\/SSA-Positive Autoimmune Fatigue Syndrome in Children","volume":"12","author":"Itoh","year":"2002","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0480","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3892\/etm.2022.11697","article-title":"TRIM21-a Potential Biomarker for the Prognosis of Thyroid Cancer","volume":"24","author":"Wu","year":"2022","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104776_b0485","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1080\/21655979.2022.2042134","article-title":"TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.cellimm.2023.104776_b0490","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2021.07.040","article-title":"TRIM21 Improves Apatinib Treatment in Gastric Cancer through Suppressing EZH1 Stability","volume":"586","author":"Ping","year":"2022","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cellimm.2023.104776_b0495","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/joim.12375","article-title":"Reduced Expression of TRIM21\/Ro52 Predicts Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients with and without Rheumatic Disease","volume":"278","author":"Brauner","year":"2015","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0500","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2003.013417","article-title":"Specific Antinuclear Antibodies Are Associated with Clinical Features in Systemic Lupus Erythematosus","volume":"63","author":"Hoffman","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cellimm.2023.104776_b0505","first-page":"1897","article-title":"Fine Specificity of Anti-Ro(SSA) Autoantibodies and Clinical Manifestations in Patients with Systemic Lupus Erythematosus","volume":"23","author":"Zimmermann","year":"1996","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/832789","article-title":"Common and Specific Associations of Anti-SSA\/Ro60 and Anti-Ro52\/TRIM21 Antibodies in Systemic Lupus Erythematosus","volume":"2013","author":"Men\u00e9ndez","year":"2013","journal-title":"Scientific World Journal"},{"issue":"7","key":"10.1016\/j.cellimm.2023.104776_b0515","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/acr2.11149","article-title":"Expanded Autoantibody Profiles for Subsetting of Native American, African American, and European American Patients With Systemic Lupus Erythematosus","volume":"2","author":"Guthridge","year":"2020","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.cellimm.2023.104776_b0520","article-title":"Sj\u00f6gren\u2019s Syndrome in Systemic Lupus Erythematosus - A Subset Characterized by a Systemic Inflammatory State","volume":"47","author":"Ruacho","year":"2010","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/415272","article-title":"Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma","volume":"2012","author":"Ferreira","year":"2012","journal-title":"ISRN Rheumatol."},{"key":"10.1016\/j.cellimm.2023.104776_b0530","doi-asserted-by":"crossref","first-page":"105895","DOI":"10.1016\/j.rmed.2020.105895","article-title":"Anti-Ro52 Antibodies Are a Risk Factor for Interstitial Lung Disease in Primary Sj\u00f6gren Syndrome","volume":"163","author":"Buvry","year":"2020","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0535","doi-asserted-by":"crossref","first-page":"106134","DOI":"10.1016\/j.rmed.2020.106134","article-title":"Anti-Ro52 Antibody Is an Independent Risk Factor for Interstitial Lung Disease in Dermatomyositis","volume":"172","author":"Xing","year":"2020","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.cellimm.2023.104776_b0540","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3899\/jrheum.161480","article-title":"Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0545","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the Treatment of Jo1 Antibody-Associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"The Journal of Rheumatology"},{"issue":"11","key":"10.1016\/j.cellimm.2023.104776_b0550","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","article-title":"Anti-Ro52 Antibodies Are Associated with the Prognosis of Adult Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease","volume":"61","author":"Gui","year":"2022","journal-title":"Rheumatol. Oxf. Engl."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104776_b0555","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between Anti-Ro52 Antibodies and Lung Fibrosis in Mixed Connective Tissue Disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatol. u. k."},{"key":"10.1016\/j.cellimm.2023.104776_b0560","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-022-06401-x","article-title":"Cardiac Involvement in Anti-MDA5 Dermatomyositis: A Case-Based Review","volume":"42","author":"Quintero-Gonz\u00e1lez","year":"2023","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0565","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10067-018-4267-z","article-title":"Myositis Autoantibody Profiles and Their Clinical Associations in Greek Patients with Inflammatory Myopathies","volume":"38","author":"Zampeli","year":"2019","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0570","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-010-1790-x","article-title":"The Prevalence and the Clinical Relevance of Anti-Ro52 in Korean Patients with Primary Sj\u00f6gren\u2019s Syndrome","volume":"32","author":"Song","year":"2012","journal-title":"Rheumatology International"},{"key":"10.1016\/j.cellimm.2023.104776_b0575","doi-asserted-by":"crossref","first-page":"e108588","DOI":"10.15252\/embj.2021108588","article-title":"A Functional Assay for Serum Detection of Antibodies against SARS-CoV-2 Nucleoprotein","volume":"40","author":"Albecka","year":"2021","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.cellimm.2023.104776_b0580","doi-asserted-by":"crossref","first-page":"13787","DOI":"10.1038\/s41598-022-17334-5","article-title":"Humoral and Cellular Response in Convalescent COVID-19 Lupus Patients","volume":"12","author":"Sol\u00e9","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.cellimm.2023.104776_b0585","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic Implications of Antibodies to Ro\/SSA and Soluble Liver Antigen in Type 1 Autoimmune Hepatitis","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver International"},{"key":"10.1016\/j.cellimm.2023.104776_b0590","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/rheumatology\/38.12.1228","article-title":"Recurrent Pregnancy Loss and Autoantibody Profile in Autoimmune Diseases","volume":"38","author":"Mavragani","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.cellimm.2023.104776_b0595","doi-asserted-by":"crossref","first-page":"e21899","DOI":"10.1097\/MD.0000000000021899","article-title":"Clinical Characteristics and Prognostic Analysis of Chinese Dermatomyositis Patients with Malignancies","volume":"99","author":"Shao","year":"2020","journal-title":"Medicine (Baltimore)"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874923001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874923001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:13:58Z","timestamp":1757805238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874923001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":119,"alternative-id":["S0008874923001156"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104776","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ro52\/TRIM21 \u2013 From host defense to autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104776"}}